Metagenics, the top doctor-recommended professional supplement brand, has announced that Patrick Sly will take over as CEO, effective immediately. Mr. Sly is a seasoned executive in the health and wellness sector and brings extensive leadership experience to the company. Pat Smallcombe, who has served as President and CEO since 2023 and guided Metagenics through a period of significant growth, will transition to the role of Co-Chair of the Board. The company is supported by Gryphon Investors, a leading middle-market private equity firm.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 26 November 2025
Ryan Fagan, Deal Partner in Gryphon’s Consumer Group, highlighted Mr. Sly’s expertise in medical nutrition, his strong partnerships with healthcare professionals, and his proven record leading global businesses. Fagan noted that Mr. Sly’s focus on integrity, innovation, and collaborative leadership aligns perfectly with Metagenics’ culture and strategic goals.
Mr. Sly has a long history of transforming large consumer health and nutrition companies into high-performing, value-generating organizations. Most recently, he served as Global President of Reckitt’s $8 billion Consumer Health division, where he drove strong profitability, regained market share momentum, and delivered sustained growth. Prior to that, he led Reckitt’s $3 billion Nutrition business, executing a global turnaround that improved margins, accelerated growth, and strengthened competitiveness.
Health Technology Insights: IMULDOSA Added to Express Scripts National Commercial Formularies
Having lived and worked in five countries, Mr. Sly brings a wealth of global experience, cultural adaptability, and strategic insight that enables him to lead diverse teams effectively. He is widely recognized for his ability to guide brand transformations, expand profitability, and deliver shareholder value while fostering inclusive, high-performance cultures.
Mr. Sly holds an MBA from Washington University in St. Louis’ Olin Business School and a Bachelor of Science in Business from Indiana University’s Kelley School of Business.
Expressing his enthusiasm, Mr. Sly said he is excited to join Metagenics at a pivotal moment. He emphasized the growth potential in the professional supplement segment and praised the company’s strong brand, clinically tested product line, and the solid foundation established by Pat Smallcombe. He looks forward to working with the team to drive the next phase of growth and expand Metagenics’ leadership in the category.
Health Technology Insights: MediView XR Earns CE Mark for Mixed Reality Technology
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
